📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Apitope

1.1 - Company Overview

Apitope Logo

Apitope

Headquarter: United Kingdom
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of discovery and development of disease-modifying therapies for autoimmune and allergic diseases, including multiple sclerosis, Graves’ disease, Factor VIII intolerance and uveitis; first product candidate licensed to Merck Serono.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Apitope

Upstream Bio Logo

Upstream Bio

HQ: United States Website
  • Description: Provider of antibody therapies targeting the TSLP receptor, developing verekitug (UPB-101), a monoclonal antibody in Phase 2 trials for severe asthma and chronic rhinosinusitis with nasal polyps (CRSwNP), and conducting research on Thymic Stromal Lymphopoietin (TSLP) as a driver of inflammatory responses in allergic and inflammatory diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Upstream Bio company profile →
Pandion Therapeutics Logo

Pandion Therapeutics

HQ: United States Website
  • Description: Provider of bispecific antibody therapeutics, modular proteins, and antibodies for localized immunomodulation at the site of disease, enabling durable, tissue-specific treatment for patients with autoimmune and inflammatory diseases and organ transplants.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Pandion Therapeutics company profile →
Abintus Bio Logo

Abintus Bio

HQ: United States Website
  • Description: Provider of in vivo immune cell reprogramming solutions, offering programs for highly selective gene expression targeting—using synthetic biology to target specific cell types or states across gene delivery systems—for applications in leukemia, solid tumors, autoimmune, infectious, and genetic diseases, and simultaneous engineering of innate and adaptive immune cells for lymphoma and solid tumors.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Abintus Bio company profile →
Amunix Logo

Amunix

HQ: United States Website
  • Description: Provider of biopharmaceutical research and development, discovering, designing, and developing novel biologics, protein, and peptide therapeutics, with a focus on prodrugs that enable potent immune-activating biotherapeutics for patients with solid tumor cancers.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Amunix company profile →
Phadia Logo

Phadia

HQ: Sweden Website
  • Description: Provider of complete blood test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; develops, manufactures and markets these systems, with more than 40 years of leadership in allergy testing.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Phadia company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Apitope

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Apitope

2.2 - Growth funds investing in similar companies to Apitope

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Apitope

4.2 - Public trading comparable groups for Apitope

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Apitope

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Apitope

What does Apitope do?

Apitope is a provider of discovery and development of disease-modifying therapies for autoimmune and allergic diseases, including multiple sclerosis, Graves’ disease, Factor VIII intolerance and uveitis; first product candidate licensed to Merck Serono.

Who are Apitope's competitors?

Apitope's competitors and similar companies include Upstream Bio, Pandion Therapeutics, Abintus Bio, Amunix, and Phadia.

Where is Apitope headquartered?

Apitope is headquartered in United Kingdom.

How many employees does Apitope have?

Apitope has 1,000 employees 🔒.

When was Apitope founded?

Apitope was founded in 2010 🔒.

What sector and industry vertical is Apitope in?

Apitope is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Apitope

Who are the top strategic acquirers in Apitope's sector and industry

Top strategic M&A buyers and acquirers in Apitope's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Apitope?

Top strategic M&A buyers groups and sectors for Apitope include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Apitope's sector and industry vertical

Which are the top PE firms investing in Apitope's sector and industry vertical?

Top PE firms investing in Apitope's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Apitope's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Apitope's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Apitope's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Apitope include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Apitope's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Apitope?

The key public trading comparables and valuation benchmarks for Apitope include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Apitope for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Apitope with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Apitope's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Apitope with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Apitope's' sector and industry vertical?

Access recent funding rounds and capital raises in Apitope's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Apitope